During the past decade, King Khaled Uni Hospital; Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "King Khaled Uni Hospital; Oncology" are "Breast Cancer" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "King Khaled Uni Hospital; Oncology" in a lesser frequency.

Most popular intervention types in "King Khaled Uni Hospital; Oncology" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "Neo-adjuvant chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Khaled Uni Hospital; Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "King Khaled Uni Hospital; Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in King Khaled Uni Hospital; Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in King Khaled Uni Hospital; Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".